Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma-Reference-Cited by-同舟云学术

Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma

Published:2011-05-11 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Ducharme Francine M,Lasserson Toby J,Cates Christopher J

Publisher

John Wiley & Sons, Ltd

Reference233 articles.

1. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial);Bjermer;Respiratory Medicine,2000

2. A one-year double-blind randomised comparative trial of montelukast and fluticasone versus salmeterol and fluticasone in protecting against asthma exacerbation in adults;Bjermer;BMJ,2003

3. Health care resource utilization following addition of montelukast or salmeterol in fluticasone in patients with inadequately controlled asthma (IMPACT trial);Bjermer;European Respiratory Journal,2004

4. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: A subgroup analysis of the improving asthma control trial;Bousquet;Clinical and Experimental Allergy,2005

5. Montelukast or salmeterol added to fluticasone in uncontrolled asthma: a subgroup analysis of the IMPACT study;Polos;The Journal of Allergy and Clinical Immunology,2003

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-leukotriene drugs in the therapy of inflammatory diseases;Prospects in Pharmaceutical Sciences;2022-08-17

2. Mise à jour des recommandations (2021) pour la prise en charge et le suivi des patients asthmatiques adultes sous l’égide de la Société de pneumologie de langue française (SPLF) et de la Société pédiatrique de pneumologie et allergologie (SP2A). Version longue;Revue des Maladies Respiratoires;2021-12

3. Usage of long-acting muscarinic antagonists and biologics as add-on therapy for patients in the United States with moderate-to-severe asthma;Journal of Asthma;2021-05-22

4. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events;Cochrane Database of Systematic Reviews;2021-04-14

5. The Type of Patients Requiring Aerosol Therapy (to Treat What and Where?);Essentials of Aerosol Therapy in Critically ill Patients;2021